Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Emerging Drugs|March 20, 2014
Emerging drugs for T-cell lymphomaMichael Dickinson, Henry Miles Prince
BMJ Case Reports|December 4, 2019
Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximabWenwen Zhang, Henry Miles Prince, Katrina Reardon
Hematology Reports|September 3, 2015
Inflammatory Pseudotumor of the SpleenMasafumi Georgia, Kirsty Rady, Henry Miles Prince
Expert Opinion on Biological Therapy|March 19, 2025
An evaluation of odronextamab for the treatment of multiple subtypes of relapsed/refractory B-cell non-Hodgkin lymphomaElena Bayly-McCredie, Henry Miles Prince, Costas Kleanthes Yannakou, et al.
Ejhaem|May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation StudyCarrie van der Weyden, Mathias Bressel, Amit Khot, et al.
Expert Opinion on Biological Therapy|February 23, 2026
An evaluation of elranatamab for the treatment of myeloma: current evidence for treating relapsed/refractory disease and future directionsElena Bayly-McCredie, Henry Miles Prince, Costas Kleanthes Yannakou, et al.
Cancers|October 13, 2021
An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell LymphomaSean Harrop, Neha Mehta-Shah, Criselle Dsouza, et al.
The Australasian Journal of Dermatology|May 26, 2026
A Case of Primary Cutaneous BRAFV600E+ Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNAKate Simpson, Friyana Bhabha, Alicia Snowden, et al.
Frontiers in Immunology|October 5, 2020
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T CellsRachel Elizabeth Cooke, Kylie Margaret Quinn, Hang Quach, et al.
International Journal of Molecular Sciences|June 15, 2018
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib TherapyLucy C Fox, Costas K Yannakou, Georgina Ryland, et al.
Pageof 3